Citadel Advisors
AGL icon

Citadel Advisors’s Agilon Health AGL Stock Holding History

Citadel Advisors’s Portfolio AGL Stock Details AGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$83.5K Buy
10,556
+2,336
+28% +$37.8K ﹤0.01% 12150
2025
Q4 		$142K Sell
8,220
-5,932
-42% -$115K ﹤0.01% 11366
2025
Q3 		$364K Sell
14,152
-6,792
-32% -$257K ﹤0.01% 9892
2025
Q2 		$1.2M Buy
20,944
+7,580
+57% +$608K ﹤0.01% 6690
2025
Q1 		$1.45M Sell
13,364
-7,392
-36% -$643K ﹤0.01% 6164
2024
Q4 		$986K Sell
20,756
-64
-0.3% -$3.87K ﹤0.01% 7051
2024
Q3 		$2.05M Buy
20,820
+6,932
+50% +$895K ﹤0.01% 5486
2024
Q2 		$2.27M Buy
13,888
+5,680
+69% +$809K ﹤0.01% 5075
2024
Q1 		$1.25M Buy
8,208
+2,016
+33% +$335K ﹤0.01% 6471
2023
Q4 		$1.94M Buy
6,192
+344
+6% +$125K ﹤0.01% 5406
2023
Q3 		$2.6M Buy
5,848
+460
+9% +$208K ﹤0.01% 4749
2023
Q2 		$2.34M Sell
5,388
-688
-11% -$387K ﹤0.01% 4888
2023
Q1 		$3.61M Sell
6,076
-1,588
-21% -$889K ﹤0.01% 4351
2022
Q4 		$3.09M Buy
7,664
+2,204
+40% +$1.03M ﹤0.01% 4707
2022
Q3 		$3.2M Buy
5,460
+3,724
+215% +$2.23M ﹤0.01% 4679
2022
Q2 		$947K Sell
1,736
-292
-14% -$148K ﹤0.01% 7141
2022
Q1 		$1.28M Buy
2,028
+740
+57% +$381K ﹤0.01% 7115
2021
Q4 		$869K Buy
+1,288
New +$784K ﹤0.01% 8294
2021
Q3 		– Sell
-392
Closed -$398K – 13728
2021
Q2 		$398K Buy
+392
New +$343K ﹤0.01% 10570

Other funds holding AGL

CDR
Clayton Dubilier & Rice New York $536M AUM 0.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
NPCM
North Peak Capital Management New York $601M AUM 0.2% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Citadel Advisors's AGL Position: Q1 2026 in Review

Citadel Advisors sold out of Agilon Health (AGL) in Q1 2026, closing a stake of 49,603 shares — an estimated $802K sold.

Citadel Advisors first reported a position in AGL in Q2 2021 and held it in 16 quarters. The position peaked at $35.1M in Q2 2021. 97 funds tracked by Wall St. Rank hold AGL as of Q1 2026.

  • Citadel Advisors reported no remaining Agilon Health position as of Q1 2026 after selling out during the quarter.
  • Citadel Advisors sold 49,603 Agilon Health shares in Q1 2026, an estimated $802K.
  • Citadel Advisors first reported a position in Agilon Health in Q2 2021 and held it in 16 quarters.
  • Citadel Advisors's Agilon Health position peaked at $35.1M in Q2 2021.
  • 97 funds tracked by Wall St. Rank held Agilon Health as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.